De novo Proteins in CSF Act as Brain Disorders Biomarkers
National Institutes of Health
Identifying and quantifying cryptic protein aggregates may help diagnose and develop therapies for brain disorders
Individuals who received two mg or three mg of Rexulti showed statistically significant and clinically meaningful improvements